ASCO 2017- A phase 1-2 study of durvalumab DURVA in combination with LEN w-wo DEX in pts with NDMM from ASCO 2017

ASCO 2017- A phase 1-2 study of durvalumab DURVA in combination with LEN w-wo DEX in pts with NDMM from ASCO 2017

1 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Up Next Autoplay